FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286251096> ?p ?o ?g. }

• W4286251096 endingPage "e10003" @default.
• W4286251096 startingPage "e10003" @default.
• W4286251096 abstract "Despite the decades of scientific studies for developing promising new therapies, cancer remains a major cause of illness and mortality, worldwide. Several cancer types are the major topic of research in drug discovery programs due to their global incidence cases and growing frequency. In the present study, using two different statistical approaches PCA (principal component analysis) and PLS (partial least squares), six 2D-QSAR (quantitative structure activity relationship) models have been developed for the set of compounds retrieved against seven cancer cell lines vizPC-3, B16F10, K562, MDA-MB-231, A2780, and ACHN. For the creation and validation of 2D-QSAR models, OECD (Organization for Economic Co-operation and Development) requirements have been strictly followed. All of the generated 2D-QSAR models produce a significant and high correlation coefficient value with several other statistical parameters. Moreover, developed 2D-QSAR models have been used for activity predictions of in-house synthesized 63 pyrazole derivatives compounds. Precisely, most statistically significant and accepted2D-QSAR model generated for each cancer cell line has been used to predict the pIC50 value (anti-cancer activity) of all 63 synthesized pyrazole derivatives. Furthermore, designing of novel pyrazole derivatives has been carried out by substituting the essential functional groups based on the best derived 2D-QSAR models for each cancer cell line, more precisely, based on the most significant molecular descriptors with enhanced anti-cancer activity. Finally, the prediction of the new designed molecules reveals higher pIC50 than the standard compounds." @default.
• W4286251096 created "2022-07-21" @default.
• W4286251096 creator A5035247447 @default.
• W4286251096 creator A5042520673 @default.
• W4286251096 creator A5045424061 @default.
• W4286251096 creator A5051521213 @default.
• W4286251096 creator A5055103206 @default.
• W4286251096 creator A5068202982 @default.
• W4286251096 creator A5069034648 @default.
• W4286251096 date "2022-08-01" @default.
• W4286251096 modified "2023-10-16" @default.
• W4286251096 title "Design and prediction of novel pyrazole derivatives as potential anti-cancer compounds based on 2D-QSAR study against PC-3, B16F10, K562, MDA-MB-231, A2780, ACHN and NUGC cancer cell lines" @default.
• W4286251096 cites W1082327261 @default.
• W4286251096 cites W1482346027 @default.
• W4286251096 cites W1508260364 @default.
• W4286251096 cites W1976043651 @default.
• W4286251096 cites W2011814974 @default.
• W4286251096 cites W2023320642 @default.
• W4286251096 cites W2024986013 @default.
• W4286251096 cites W2034850229 @default.
• W4286251096 cites W2035252444 @default.
• W4286251096 cites W2067255270 @default.
• W4286251096 cites W2075214529 @default.
• W4286251096 cites W2131487381 @default.
• W4286251096 cites W2141779932 @default.
• W4286251096 cites W2339094353 @default.
• W4286251096 cites W2411330078 @default.
• W4286251096 cites W2616823333 @default.
• W4286251096 cites W2734713150 @default.
• W4286251096 cites W2751109670 @default.
• W4286251096 cites W2765528155 @default.
• W4286251096 cites W2790833123 @default.
• W4286251096 cites W2803827969 @default.
• W4286251096 cites W2891123788 @default.
• W4286251096 cites W2895650761 @default.
• W4286251096 cites W2914384984 @default.
• W4286251096 cites W2932074140 @default.
• W4286251096 cites W2937483840 @default.
• W4286251096 cites W2943415606 @default.
• W4286251096 cites W3013960002 @default.
• W4286251096 cites W3032630518 @default.
• W4286251096 cites W3039690610 @default.
• W4286251096 cites W3049551645 @default.
• W4286251096 cites W3113016640 @default.
• W4286251096 cites W4210899999 @default.
• W4286251096 doi "https://doi.org/10.1016/j.heliyon.2022.e10003" @default.
• W4286251096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35965973" @default.
• W4286251096 hasPublicationYear "2022" @default.
• W4286251096 type Work @default.
• W4286251096 citedByCount "4" @default.
• W4286251096 countsByYear W42862510962022 @default.
• W4286251096 countsByYear W42862510962023 @default.
• W4286251096 crossrefType "journal-article" @default.
• W4286251096 hasAuthorship W4286251096A5035247447 @default.
• W4286251096 hasAuthorship W4286251096A5042520673 @default.
• W4286251096 hasAuthorship W4286251096A5045424061 @default.
• W4286251096 hasAuthorship W4286251096A5051521213 @default.
• W4286251096 hasAuthorship W4286251096A5055103206 @default.
• W4286251096 hasAuthorship W4286251096A5068202982 @default.
• W4286251096 hasAuthorship W4286251096A5069034648 @default.
• W4286251096 hasBestOaLocation W42862510961 @default.
• W4286251096 hasConcept C119857082 @default.
• W4286251096 hasConcept C121608353 @default.
• W4286251096 hasConcept C126322002 @default.
• W4286251096 hasConcept C154945302 @default.
• W4286251096 hasConcept C164126121 @default.
• W4286251096 hasConcept C185592680 @default.
• W4286251096 hasConcept C22354355 @default.
• W4286251096 hasConcept C27438332 @default.
• W4286251096 hasConcept C2777682936 @default.
• W4286251096 hasConcept C2994372470 @default.
• W4286251096 hasConcept C41008148 @default.
• W4286251096 hasConcept C70721500 @default.
• W4286251096 hasConcept C71240020 @default.
• W4286251096 hasConcept C71924100 @default.
• W4286251096 hasConcept C86803240 @default.
• W4286251096 hasConcept C96232424 @default.
• W4286251096 hasConceptScore W4286251096C119857082 @default.
• W4286251096 hasConceptScore W4286251096C121608353 @default.
• W4286251096 hasConceptScore W4286251096C126322002 @default.
• W4286251096 hasConceptScore W4286251096C154945302 @default.
• W4286251096 hasConceptScore W4286251096C164126121 @default.
• W4286251096 hasConceptScore W4286251096C185592680 @default.
• W4286251096 hasConceptScore W4286251096C22354355 @default.
• W4286251096 hasConceptScore W4286251096C27438332 @default.
• W4286251096 hasConceptScore W4286251096C2777682936 @default.
• W4286251096 hasConceptScore W4286251096C2994372470 @default.
• W4286251096 hasConceptScore W4286251096C41008148 @default.
• W4286251096 hasConceptScore W4286251096C70721500 @default.
• W4286251096 hasConceptScore W4286251096C71240020 @default.
• W4286251096 hasConceptScore W4286251096C71924100 @default.
• W4286251096 hasConceptScore W4286251096C86803240 @default.
• W4286251096 hasConceptScore W4286251096C96232424 @default.
• W4286251096 hasIssue "8" @default.
• W4286251096 hasLocation W42862510961 @default.
• W4286251096 hasLocation W42862510962 @default.
• W4286251096 hasLocation W42862510963 @default.
• W4286251096 hasLocation W42862510964 @default.

• next